Open Access
Subscription Access
Open Access
Subscription Access
Contribution of Traditional Medicines to the Development of Modern Medicine for Malaria
Subscribe/Renew Journal
Malaria is caused by protozoan parasites of the genus Plasmodium. The most serious forms of the disease are caused by Plasmodium falciparum and Plasmodium vivax, but other related species (Plasmodium ovale, Plasmodium malariae) can also affect humans. The initial symptoms of malaria which include fever, headache and muscular aches. Plasmodium develops in the gut of the mosquito and passed in the saliva of an infected insect each time it takes a new blood meal. The parasites are then carried by the blood in the victim's liver where they invade the cells and multiply. After 9-16 days they return to the blood and penetrate the red cells, where they multiply again, progressively breaking down the red cells. In cerebral malaria, the infected red cells obstruct the blood vessels in the brain. The four species of malaria are distinguished by their different appearances of Trophozoites, Schizonts, Gametocytes and staining, size and shape of infected red blood cells, and other characteristics. The key role of traditional medicine in the development of modern medicine for prevention of malaria is discussed in this article. In-vitro and in-vivo antiplasmodial activities are experimental models for detecting antiplasmodial activity of plant extracts in the erythrocytic stage of malaria parasites. The study is likely to promote a rational use of botanicals and must be continued focusing on the isolation and characterizing active principles of the crude extract, its pharmacological validation, standardization and formulation.
Keywords
Malaria, Plasmodium falciparum, Antiplasmodial Activity.
Subscription
Login to verify subscription
User
Font Size
Information
- Cox F. History of human parasitology. Clinical Microbiol Rev. 2002; 15 (4): 595-612.
- Breman J. The ears of hippopotamus: manifestations, determinants and estimates of the malarial burden. Am J Trop Med Hyg. 2001; 64 (1-2): 1-11.
- Greenword BM, Bojang K, Whitty CJ and Targett GA. Malaria. Lancet. 2005; 365: 1487-1498.
- Van Benthem B, Vanwambeke S, Khantikul N, Burghoorn-Mass C, Panart K, Oskam L, Lambin E and Samboon P. Spatial patterns of and risk factors for seropositivity for dengue infection. Am J Trop Med Hyg. 2005; 72(2): 201-208.
- http://www.ciisocialcouncil.org
- http://www.health.sa.gov.au
- Foley M and Tilley L. Quinoline antimalarials: Mechanism of action and resistance and prospects for new agents. Pharmacol Ther. 1998; 79: 55-87.
- http://www.textbooksonline.tn.nic.in
- http://www.malaria.org.za
- Tinto H, Rwagacondo C and Karema C. In-vitro suceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisin and quinine in an area of high chloroquine esistance in Rwand. Trans R Soc Trop Med Hyg. 100 (6): 509-514.
- Ridley RG. Medical need, scientific opportunity and drive for antimalarial drugs. Nature. 2002; 415: 686-693.
- Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH and Bygbjerg IC. High level of resistance of P. falciparum to sulfadoxime-pyrimethamine in children in Tanzania. Trans R Soc Trop Med Hyg. 1996; 90: 179-181.
- Sowunmi A, Oduola AM, Ogundahunsi OA and Salako LA. Comparitive efficacy of chlroquine plus chlorophenaramine and pyrimethamina/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. Trans R Soc Trop Med Hyg. 1998; 92: 77-81.
- White NJ. Drug resistance in malaria. Br Med Bull. 1998. 54: 703-715.
- Foote SJ and Cowman AF. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop. 1994; 56: 157-171.
- Ward SA, Bray BG, Mungthin M and Hawley SR. Current views on the mechanism of resistance to quinoline containing drugs in P. falciparum. Ann Trop Med Parasitol. 1995; 89: 121-124.
- Chawira AN and Warhurst DC. The effect of Artemisinin combined with standard antimalarils against chloroquine sensitive and chloroquine resistant strains of P. falciparum invitro. J Trop med Hyg. 1987; 90: 1-8.
- Olliaro PL and Trigg PI. Status of antimalarial drugs under development. Bull World Health Organ. 1995; 73: 565-571.
- Willcox M and Bodeker G. An Overview of Ethnobotonical Studies on Plants Used for the treatment of Malaria. In Merlin Willcox, Gerard Bodeker and Philippe Rasoanaivo's. Traditional medicinal Plants and Malaria. CRC Press, London.
Abstract Views: 288
PDF Views: 2